Sanofi (SNYNF)
91.10
+1.43
(+1.59%)
USD |
OTCM |
Aug 28, 16:00
Sanofi Price to Book Value : 1.534 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.534 |
| August 27, 2026 | 1.510 |
| August 26, 2026 | 1.510 |
| August 25, 2026 | 1.559 |
| August 24, 2026 | 1.559 |
| August 21, 2026 | 1.574 |
| August 20, 2026 | 1.525 |
| August 19, 2026 | 1.525 |
| August 18, 2026 | 1.516 |
| August 17, 2026 | 1.464 |
| August 14, 2026 | 1.484 |
| August 13, 2026 | 1.467 |
| August 12, 2026 | 1.467 |
| August 11, 2026 | 1.466 |
| August 10, 2026 | 1.446 |
| August 07, 2026 | 1.489 |
| August 06, 2026 | 1.470 |
| August 05, 2026 | 1.400 |
| August 04, 2026 | 1.400 |
| August 03, 2026 | 1.412 |
| July 31, 2026 | 1.413 |
| July 30, 2026 | 1.396 |
| July 29, 2026 | 1.530 |
| July 28, 2026 | 1.502 |
| July 27, 2026 | 1.491 |
| Date | Value |
|---|---|
| July 24, 2026 | 1.487 |
| July 23, 2026 | 1.487 |
| July 22, 2026 | 1.440 |
| July 21, 2026 | 1.482 |
| July 20, 2026 | 1.493 |
| July 17, 2026 | 1.465 |
| July 16, 2026 | 1.465 |
| July 15, 2026 | 1.465 |
| July 14, 2026 | 1.424 |
| July 13, 2026 | 1.456 |
| July 10, 2026 | 1.488 |
| July 09, 2026 | 1.473 |
| July 08, 2026 | 1.401 |
| July 07, 2026 | 1.436 |
| July 06, 2026 | 1.436 |
| July 02, 2026 | 1.427 |
| July 01, 2026 | 1.369 |
| June 30, 2026 | 1.407 |
| June 29, 2026 | 1.421 |
| June 26, 2026 | 1.435 |
| June 25, 2026 | 1.435 |
| June 24, 2026 | 1.405 |
| June 23, 2026 | 1.405 |
| June 22, 2026 | 1.405 |
| June 18, 2026 | 1.498 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ipsen SA | -- |
| AB Science SA | -- |
| MedinCell SA | -- |
| Vétoquinol SA | -- |
| Pfizer Inc. | 1.870 |
Price to Book Value Related Metrics
| PE Ratio | 23.46 |
| PS Ratio | 2.059 |
| PEG Ratio | 3.330 |
| Price to Free Cash Flow | 11.13 |
| Price | 91.10 |
| Earnings Yield | 4.26% |
| Market Cap | 110.61B |
| PEGY Ratio | 1.897 |
| Operating PE Ratio | 7.576 |
| Normalized PE Ratio | 13.26 |